What makes COVAX special is that it's a pooled procurement mechanism. It takes the demand from, say, 92 developing countries and is able to negotiate better prices and access as a result of that, and then it “bulk procures” doses to then allocate to its members.
On March 21st, 2022. See this statement in context.